Planning Comparison of TomoTherapy with Standard Multi-Leaf IMRT and Conventional AP/PA Fields in the Treatment of Advanced Nodular Sclerosing Hodgkin's Lymphoma
Brian Wichman, DABR
April 16, 2010
Kansas City Cancer Center (KCCC) treats patients at 11 facilities in the metropolitan area, and is the only Kansas City provider to offer TomoTherapy treatments. In this presentation, we hear how KCCC chose TomoTherapy technology for an advanced Hodgkin's Lymphoma case after a planning comparison revealed lung dose to be unacceptable with a conventional AP/PA technique, and sub-optimal with standard 9-field IMRT. "TomoTherapy did a better job of protecting the lung and covered our PTV as well or better than other techniques," said KCCC's chief medical physicist, Brian Wichman, DABR. Comparison results were shared with the patient, who delighted in staying close to home for the TomoTherapy treatments.
Link to this comment:
All Comments (0)